GL1X · GenesisL1 explorer

UniProt P53350

Serine/threonine-protein kinase PLK1 (P53350)

Serine/threonine-protein kinase PLK1 (UniProt P53350), EC 2.7.11.21: 130 experimental structures on GenesisL1, 11 ligands bound, 20 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.

UniProt
P53350
Protein
Serine/threonine-protein kinase PLK1
EC
2.7.11.21
Experimental structures
130
Predicted models
0
Ligands
11
Pockets
20 · 3 records with a druggable one

Structures

130 records of P53350 in the MolNFT archive: 130 experimental, 0 predicted.

EntryTitleMethodChainsLigandsPockets
1Q4KThe polo-box domain of Plk1 in complex with a phospho-peptidex-ray diffractionB, A, C——
1Q4KThe polo-box domain of PLK1 in complex with a phospho- peptidex-ray diffractionB, A, C——
1Q4OThe structure of the polo box domain of human Plk1x-ray diffractionA, B——
1Q4OThe structure of the polo box domain of human PLK1x-ray diffractionA, B——
1UMWStructure of a human Plk1 Polo-box domain/phosphopeptide complexx-ray diffractionA, B——
1UMWStructure of a human PLK1 polo-box DOMAIN/PHOSPHOPEPTIDE complexx-ray diffractionA, B——
2OGQMolecular and structural basis of Plk1 substrate recognition: Implications in centrosomal…x-ray diffractionA——
2OGQMolecular and structural basis of PLK1 substrate recognition: implications in centrosomal…x-ray diffractionA——
2OJXMolecular and structural basis of polo-like kinase 1 substrate recognition: Implications in…x-ray diffractionA——
2OJXMolecular and structural basis of polo-like kinase 1 substrate recognition: implications in…x-ray diffractionA——
2OU7Structure of the Catalytic Domain of Human Polo-like Kinase 1x-ray diffractionA——
2OU7Structure of the catalytic domain of human polo-like kinase 1x-ray diffractionA——
2OWBStructure of the Catalytic Domain of Human Polo-like Kinase 1x-ray diffractionA——
2OWBStructure of the catalytic domain of human polo-like kinase 1x-ray diffractionA——
2RKUStructure of PLK1 in complex with BI2536x-ray diffractionA——
2RKUStructure of PLK1 in complex with BI2536x-ray diffractionA——
2V5QCrystal structure of wild-type plk-1 kinase domain in complex with a selective darpinx-ray diffractionA, B——
2V5QCrystal structure of wild-type plk-1 kinase domain in complex with a selective darpinx-ray diffractionA, B——
2YACCrystal structure of Polo-like kinase 1 in complex with NMS-P937x-ray diffractionA——
2YACCrystal structure of polo-like kinase 1 in complex with nms-P937x-ray diffractionA——
3BZIMolecular and structural basis of polo-like kinase 1 substrate recognition: Implications in…x-ray diffractionA——
3BZIMolecular and structural basis of polo-like kinase 1 substrate recognition: implications in…x-ray diffractionA——
3C5LPolo-like kinase 1 Polo box domain in complex with PPHSpT peptidex-ray diffractionA——
3C5LPolo-like kinase 1 polo box domain in complex with pphspt peptidex-ray diffractionA——
3FC2PLK1 in complex with BI6727x-ray diffractionA——
3FC2PLK1 in complex with BI6727x-ray diffractionA——
3FVHPolo-like kinase 1 Polo box domain in complex with Ac-LHSpTA-NH2 peptidex-ray diffractionA——
3FVHPolo-like kinase 1 polo box domain in complex with ac-lhspta-NH2 peptidex-ray diffractionA——
3HIHStructure of human Plk1-PBD with glycerol and sulfate in the phophopeptide binding sitex-ray diffractionA, B——
3HIHStructure of human PLK1-pbd with glycerol and sulfate in the phophopeptide binding sitex-ray diffractionA, B——
3HIKStructure of human Plk1-PBD in complex with PLHSpTx-ray diffractionA——
3HIKStructure of human PLK1-pbd in complex with plhsptx-ray diffractionA——
3KB7Crystal structure of Polo-like kinase 1 in complex with a pyrazoloquinazoline inhibitorx-ray diffractionA——
3KB7Crystal structure of polo-like kinase 1 in complex with a pyrazoloquinazoline inhibitorx-ray diffractionA——
3P2WUnliganded form of Polo-like kinase I Polo-box domainx-ray diffractionA——
3P2WUnliganded form of polo-like kinase I polo-box domainx-ray diffractionA——
3P2ZPolo-like kinase I Polo-box domain in complex with PLHSpTA phosphopeptide from PBIP1x-ray diffractionA——
3P2ZPolo-like kinase I polo-box domain in complex with plhspta phosphopeptide from PBIP1x-ray diffractionA——
3P34Polo-like kinase I Polo-box domain in complex with MQSpTPL phosphopeptidex-ray diffractionA——
3P34Polo-like kinase I polo-box domain in complex with mqsptpl phosphopeptidex-ray diffractionA——
3P35Polo-like kinase I Polo-box domain in complex with MQSpSPL phosphopeptidex-ray diffractionA, B, C——
3P35Polo-like kinase I polo-box domain in complex with mqspspl phosphopeptidex-ray diffractionA, B, C——
3P36Polo-like kinase I Polo-box domain in complex with DPPLHSpTA phosphopeptide from PBIP1x-ray diffractionA——
3P36Polo-like kinase I polo-box domain in complex with dpplhspta phosphopeptide from PBIP1x-ray diffractionA——
3P37Polo-like kinase I Polo-box domain in complex with FDPPLHSpTA phosphopeptide from PBIP1x-ray diffractionA, B, C——
3P37Polo-like kinase I polo-box domain in complex with fdpplhspta phosphopeptide from PBIP1x-ray diffractionA, B, C——
3Q1IPolo-like kinase I Polo-box domain in complex with FMPPPMSpSM phosphopeptide from TCERG1x-ray diffractionA——
3Q1IPolo-like kinase I polo-box domain in complex with fmpppmspsm phosphopeptide from TCERG1x-ray diffractionA——
3RQ7Polo-like kinase 1 Polo box domain in complex with a C6H5(CH2)8-derivatized peptide inhibitorx-ray diffractionA——
3RQ7Polo-like kinase 1 polo box domain in complex with a C6H5(CH2)8- derivatized peptide inhibitorx-ray diffractionA——
3THBStructure of PLK1 kinase domain in complex with a benzolactam-derived inhibitorx-ray diffractionA——
3THBStructure of PLK1 kinase domain in complex with a benzolactam-derived inhibitorx-ray diffractionA——
4A4LCrystal structure of polo-like kinase 1 in complex with a 5-(2-amino- pyrimidin-4-yl)-1H-pyrrole…x-ray diffractionA——
4A4LCrystal structure of polo-like kinase 1 in complex with a 5-(2-amino- pyrimidin-4-yl)-1H-pyrrole…x-ray diffractionA——
4A4OCrystal structure of polo-like kinase 1 in complex with a 2-(2-amino…x-ray diffractionA——
4A4OCrystal structure of polo-like kinase 1 in complex with a 2-(2-amino…x-ray diffractionA——
4DFWOxime-based Post Solid-phase Peptide Diversification: Identification of High Affinity Polo-like…x-ray diffractionA——
4DFWOxime-based post solid-phase peptide diversification: identification of high affinity polo-like…x-ray diffractionA——
4E67The structure of the polo-box domain (PBD) of polo-like kinase 1 (Plk1) in complex with…x-ray diffractionA——
4E67The structure of the polo-box domain (pbd) of polo-like kinase 1 (PLK1) in complex with…x-ray diffractionA——

70 records more on the page itself.

Ligands

  • 8Z5 · Alpha-Bromo-3-Iodotoluene · in 4 records
  • ZN · Zinc ion · in 3 records
  • AML · Amylamine · in 2 records
  • Z24 · (3~{R},5~{R})-1-[2,4-bis(fluoranyl)phenyl]-5-oxidanyl-pyrrolidine-3-carboxylic acid · in 2 records
  • ZOY · N-[(4S)-4,5-diamino-5-oxopentyl]-10-phenyldecanamide · in 2 records
  • 79C · 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-yl) amino]-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide · in 1 record
  • 79D · 4-{[(6R)-7-cyano-5-cyclopentyl-6-ethyl-5,6-dihydroimidazo[1,5-f]pteridin-3-yl]amino}-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide · in 1 record
  • 8VB · 2-[[3-[[5-(3-iodanylphenyl)carbonylthiophen-2-yl]carbonylamino]phenyl]methyl]propanedioic acid · in 1 record
  • 8X7 · 1-[6-(2-hydroxypropan-2-yl)pyridin-2-yl]-6-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-2-(prop-2-en-1-yl)-1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-one · in 1 record
  • ACE · Acetyl group · in 1 record
  • ZO1 · 3-(trifluoromethyl)benzaldehyde · in 1 record

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.